Skip to Content

Soliris 300 mg concentrate for solution for infusion

Licence status
Authorised:
Active substances
Eculizumab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/07/393/001
Licence holder
Alexion Europe SAS

Licence information

ATC code
L04AA Selective immunosuppressants, L04AA25 eculizumab
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued